Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
Luís R. Lopes(Barts Health NHS Trust), Н. Н. Чакова, Perry Elliott(St Bartholomew's Hospital), Andrzej Budaj, Juan R. Gimeno(Universidad de Murcia), Aleksandr Nedoshivin, Philippe Charron(Inserm), Alastair Gray(University of Oxford), Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Luigi Tavazzi(Maria Cecilia Hospital), Jonathan Emberson(University of Oxford), José Manuel García‐Pinilla(Centro de Investigación Biomédica en Red), Anna-Sonia Petronio, Eduardo Villacorta(Complejo Hospitalario de Salamanca), Dulce Brito(University of Lisbon), Juan Pablo Kaski(Great Ormond Street Hospital), Jens Mogensen(Odense University Hospital), Jelena Čelutkienė(Vilnius University), С. М. Комиссарова, Chris P Gale(University of Leeds), Michael Glikson(Hadassah Medical Center), Albert Hagège, Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Lars Wallentin(Uppsala University), Hubert Seggewiß(Leopoldina Krankenhaus Schweinfurt), Nikolaos Dagres(Leipzig University), Klaudia Vivien Nagy(Universitätsmedizin Göttingen), Michał Tendera, Aleš Linhart(Charles University), David Erlinge(Lund University), Uwe Zeymer(University of Freiburg), Aldo P. Maggioni(Health Care Foundation), Tomás Ripoll‐Vera(Hospital Son Llatzer), Maria Angela Losi, Nabeel Sheikh(St Thomas' Hospital), Cécile Laroche(European Society of Cardiology), Jolien Roo Hesselink, Eloisa Arbustini(Policlinico San Matteo Fondazione), Branko Beleslin(University of Belgrade), Meral Kayıkçıoğlu
European Heart Journal - Quality of Care and Clinical Outcomes
February 4, 2022
Cited by 45
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
|The Lancet|2015|3.7k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k